Azitra (AZTR) Accumulated Expenses (2022 - 2026)
Azitra (AZTR) reported Accumulated Expenses of $270511.0 for Q1 2026, down 42.12% on a YoY basis from $467394.0 in Q1 2025, and up 36.98% quarter-over-quarter from $197484.0 in Q4 2025.
Azitra (AZTR) Accumulated Expenses (2022 - 2026) Analysis & Trends
Azitra has reported Accumulated Expenses for 5 years, with the latest figure at $270511.0 in Q1 2026.
- For the quarter ending Q1 2026, Accumulated Expenses fell 42.12% year-over-year to $270511.0; the trailing twelve-month figure through Mar 2026 stood at $270511.0 (down 42.12% YoY), and the FY2025 full-year result was $197484.0, down 67.24% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $270511.0, up from $197484.0 in the prior quarter.
- The five-year high for Accumulated Expenses was $767721.0 in Q2 2023, with the low at $27082.0 in Q4 2022.
- Historically, Accumulated Expenses has averaged $389624.5 across 5 years, with a median of $434103.0 in 2024.
- Annual changes were most pronounced in 2023 — Accumulated Expenses jumped 1316.69% — and 2025, when it slumped 67.24%.
- Azitra's Accumulated Expenses stood at $27082.0 in 2022, then jumped by 1316.69% to $383668.0 in 2023, then jumped by 57.11% to $602787.0 in 2024, then tumbled by 67.24% to $197484.0 in 2025, then soared by 36.98% to $270511.0 in 2026.
- The last three Accumulated Expenses figures came in at $270511.0 (Q1 2026), $197484.0 (Q4 2025), and $507329.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Azitra | 20,900.00 | 20,900.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 270,511.00 |
| Dec 31, 2025 | 197,484.00 |
| Sep 30, 2025 | 507,329.00 |
| Jun 30, 2025 | 513,166.00 |
| Mar 31, 2025 | 467,394.00 |
| Dec 31, 2024 | 602,787.00 |
| Sep 30, 2024 | 486,981.00 |
| Jun 30, 2024 | 434,103.00 |
| Mar 31, 2024 | 348,930.00 |
| Dec 31, 2023 | 383,668.00 |
| Sep 30, 2023 | 57,963.00 |
| Jun 30, 2023 | 767,721.00 |
| Dec 31, 2022 | 27,082.00 |